TRETINOIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 30 adverse event reports in the FDA FAERS database where TRETINOIN was used for Psoriasis.
Most Reported Side Effects for TRETINOIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 665 | 16.1% | 152 | 179 |
| Drug ineffective | 537 | 13.0% | 158 | 123 |
| Product use in unapproved indication | 466 | 11.3% | 145 | 98 |
| Vomiting | 286 | 6.9% | 127 | 109 |
| Paraesthesia | 284 | 6.9% | 116 | 81 |
| Pain | 270 | 6.5% | 115 | 81 |
| Drug intolerance | 263 | 6.4% | 131 | 92 |
| Maternal exposure during pregnancy | 261 | 6.3% | 182 | 101 |
| Taste disorder | 258 | 6.2% | 128 | 88 |
| Differentiation syndrome | 251 | 6.1% | 29 | 118 |
| Epilepsy | 251 | 6.1% | 122 | 73 |
| Abdominal pain upper | 247 | 6.0% | 113 | 79 |
| Hypoaesthesia | 247 | 6.0% | 107 | 69 |
| Blepharospasm | 238 | 5.8% | 109 | 73 |
| Gastrooesophageal reflux disease | 237 | 5.7% | 107 | 71 |
Other Indications for TRETINOIN
Acute promyelocytic leukaemia (1,393)
Product used for unknown indication (883)
Acne (442)
Acute myeloid leukaemia (284)
Skin wrinkling (248)
Off label use (55)
Product use in unapproved indication (43)
Skin disorder (42)
Therapeutic skin care topical (37)
Immune thrombocytopenic purpura (34)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)